Business Wire

Insulet Issued Voluntary Medical Device Correction for Omnipod DASH® Personal Diabetes Manager on October 17, 2022

ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), announced on October 17, 2022, a Medical Device Correction for all Omnipod DASH® Personal Diabetes Managers ...
FierceBiotech

Insulet braces for $40M hit from replacing faulty remotes for Omnipod Dash insulin pumps

Insulet has begun a voluntary recall of the remote-control devices used with its Omnipod Dash insulin pumps after discovering that the devices’ batteries may be at risk of swelling, leaking or ...
Nasdaq

Insulet's Omnipod 5 Study Data Shows Improvements In Glycemic Control With One Year Of Use

(RTTNews) - Insulet Corp. (PODD) said that Omnipod 5 Automated Insulin Delivery System, the world's first tubeless, wearable system that continuously adapts insulin delivery based on glucose levels ...
Business Wire

Insulet to Present Extended Real-World Evidence and Best Practices for Optimizing Care with Omnipod ® 5

ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced ...